-
181
Figure 1 from Spatially Resolved Transcriptomics Deconvolutes Prognostic Histological Subgroups in Patients with Colorectal Cancer and Synchronous Liver Metastases
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
182
Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
183
Supplementary Figure S3 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
184
Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
185
Supplementary Figure S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
186
Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
187
Supplementary Figure S7 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
188
Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
189
TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
190
Supplementary Tables S1-S15 from Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
191
Supplementary Table S2 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TN...
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
192
Supplementary Table S3 from Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TN...
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
193
Supplementary Figure S3 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
194
Supplementary Figure S4 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
195
Supplementary Figure S5 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
196
Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
197
Supplementary Figure S2 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
198
Supplementary Figure S1 from IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
199
Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmo...
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”
-
200
Supplementary Figure S1 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmo...
Baskı/Yayın Bilgisi 2025Konular: “…Cancer Detection and Diagnosis…”